Filing metadata

Accession number
0001357550-22-000107
Form type
Form 3
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Sep 28, 2022
Reporting period
Sep 19, 2022
Description
Initial ownership

Explore SEC Filings Hub